Effectiveness of Casirivimab-Imdevimab Monoclonal Antibody Treatment among High-Risk Patients with Severe Acute Respiratory Syndrome Coronavirus 2 B.1.617.2 (Delta Variant) Infection

Mohanad M. Al-Obaidi, Ahmet B. Gungor, Saman Nematollahi, Tirdad T Zangeneh, Edward J. Bedrick, Katherine M. Johnson, Nicole E. Low-Adegbija, Ruhaniyah Alam, Pooja Rangan, C. William Heise, Venkatesh K. Ariyamuthu, Aneesha Shetty, Abd Assalam Qannus, Sangeetha Murugapandian, Mehmet M.S. Ayvaci, Prince Mohan Anand, Bekir Tanriover

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Effectiveness of Casirivimab-Imdevimab Monoclonal Antibody Treatment among High-Risk Patients with Severe Acute Respiratory Syndrome Coronavirus 2 B.1.617.2 (Delta Variant) Infection'. Together they form a unique fingerprint.

Medicine & Life Sciences